Joint fusion of sequences and structures of drugs and targets for identifying targets based on intra and inter cross-attention mechanisms.
Journal:
BMC biology
Published Date:
Jul 1, 2025
Abstract
BACKGROUND: Accurately identifying targets not only guides treatments for diseases with unclear pathogenic mechanisms, but also reduces pharmaceutical costs and accelerates drug development timelines. However, the primary challenge in targets identification currently lies in the low accuracy of existing computational methods.
Authors
Keywords
No keywords available for this article.